Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Narinder Pal Bhalla currently holds 82,194 shares of Lexeo Therapeutics, Inc. (LXEO), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Narinder Pal Bhalla has been a net seller of LXEO stock. They have purchased $0 and sold $98.6K worth of shares.
Narinder Pal Bhalla's most recent insider trade was on Jul 1, 2026, when they sold 22,306 shares at $4.42 per share.
Narinder Pal Bhalla serves as Chief Medical Officer at Lexeo Therapeutics, Inc. (LXEO). They have executed 2 insider transactions totaling $98.6K over their tenure at the company.
Narinder Pal Bhalla holds the position of Chief Medical Officer at Lexeo Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Narinder Pal Bhalla has shown a selling trading pattern, with $0 in total purchases and $98.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Narinder Pal Bhalla was on Jul 1, 2026, when they sold $98.6K worth of LXEO shares. This transaction involved 22,306 shares at $4.42 per share.
Narinder Pal Bhalla currently owns 82,194 shares of Lexeo Therapeutics, Inc. (LXEO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Narinder Pal Bhalla's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Narinder Pal Bhalla has 2 Form 4 filings on record as an insider at Lexeo Therapeutics, Inc..
Set alerts for Narinder Pal Bhalla and 40,000+ other insiders.